Merck, BioMed X Institute collaboratively complete 4th project in Oncology Ruchika Sharma4 Nov 2021 3:03 PM ISTHeidelberg: German independent research institute BioMed X has recently announced the successful completion of the research project DNA...
Zeris Pharma, Merck ink pact for XeriJect Ruchika Sharma27 Oct 2021 11:00 AM ISTChicago: Xeris Biopharma Holdings, Inc., a biopharmaceutical company developing and commercializing unique therapies for patient populations in...
Merck Keytruda in combination with chemotherapy gets European nod as treatment for breast cancer Ruchika Sharma24 Oct 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the European Commission (EC) has approved KEYTRUDA,...
WHO-led program aims to purchase antiviral COVID pills for USD 10 Ruchika Sharma19 Oct 2021 10:00 AM ISTBrussels: A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to...
Merck COVID-19 drug sparks calls for access for lower income countries Ruchika Sharma18 Oct 2021 3:38 PM ISTNew Delhi: The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution,...
Will ask experts to scrutinize Merck Covid-19 pill in late November: FDA Ruchika Sharma16 Oct 2021 1:05 PM ISTWashington: The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck's pill to...
Everest Organics begins making API for Merck Molnupiravir Ruchika Sharma13 Oct 2021 3:13 PM ISTNew Delhi: India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of...
Merck launches RonaCare Epintegrity to strengthen skin resilience Ruchika Sharma12 Oct 2021 2:23 PM ISTGermany: Merck, a science and technology company, has introduced its new cosmetic ingredient RonaCare Epintegrity. The product was developed to help...
Merck seeks USFDA authorization for anti-COVID pill Molnupiravir Ruchika Sharma12 Oct 2021 1:06 PM ISTNew Delhi: Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use...
Merck completes enrolment of Evobrutinib Phase III Trials ahead of ECTRIMS 2021 Ruchika Sharma5 Oct 2021 10:00 AM ISTDarmstadt: Merck, a science and technology company, has recently announced enrolment has been completed in the Phase III EVOLUTION RMS clinical trial...
Merck to buy Acceleron Pharma Ruchika Sharma3 Oct 2021 10:00 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Acceleron Pharma Inc., a publicly traded biopharmaceutical company, have...
Molnupiravir likely to be effective against known COVID variants: Merck Medical Dialogues Bureau2 Oct 2021 10:00 AM ISTNew Delhi: Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against...
